Delivery Order SPE2DB20D3103-SPE2DB25FN5J7
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 160 mg/16 ml vials of the medication Docetaxel, a chemotherapy drug. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $3,916.80 and a period of performance through May 8, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $7,315.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 160 mg/16 ml vials of the cancer medication docetaxel. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,975,167 units of Docetaxel 80 mg/4 ml vial 4 ml, a specialty medication. The contract has a firm fixed price of $1,317.74 and a completion date of January 21, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,387.22, is for the supply of 4,564,688,768 mL of the pharmaceutical product Docetaxel 160 mg/16 mL. The order has a firm fixed-price pricing type and a completion date of May 23, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award is a delivery order valued at $8,071.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100mg doses of the chemotherapy drug paclitaxel, a common cancer treatment medication. The award has a firm fixed price and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,441.73, is for the delivery of pharmaceutical and medical products to support military healthcare programs. It is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $28,080.24, is for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,734.15, is for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. The contract is not designated as a set-aside, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,505.36, is for the supply of various pharmaceutical products and medical supplies to support military healthcare programs. It is a firm fixed-price contract with a period of performance through May 15, 2025. The contract is not set aside for any small business or socioeconomic category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,793.24, is for the provision of pharmaceutical and medical supplies to support federal government agencies, including the Defense Health Agency and U.S. Coast Guard. The contract is a Firm Fixed Price, non-set-aside delivery order with a performance period through May 6, 2025....